Trial Radar KI

Lassen Sie uns klinische Studien mit MD Anderson Krebszentrum als Hauptsponsor oder Kooperationspartner besprechen und erkunden.

Es werden klinische Studien passend zu Standort: MD Anderson Cancer Center angezeigt.

Fragen zu Gesundheitszuständen, Behandlungen oder möchten Sie klinische Studien bei Ihnen finden?
Unsere Suchfunktion unterstützt derzeit nur Englisch. Für die Suche und Diskussion in anderen Sprachen verwenden Sie bitte die oben stehende Klinische Studien Radar KI oder wählen Sie unten die Erkrankungs- und Standortfilter aus.
44 klinische Studien
 
Status (Standard)
Noch Nicht Rekrutierend, Offene Rekrutierung, Aktiv, Nicht Rekrutierend
×
 
Standort
MD Anderson Cancer Center
×
 
Titel der Studie
Status
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer NCT07500298
Noch nicht rekrutierend
Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study) NCT07475923
Noch nicht rekrutierend
A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In BRAF Wild-Type Anaplastic Thyroid Cancer: The ZEPHYR Trial NCT07470489
Noch nicht rekrutierend
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers NCT07467109
Noch nicht rekrutierend
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System NCT07444645
Noch nicht rekrutierend
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies NCT07444632
Noch nicht rekrutierend
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas NCT07444619
Noch nicht rekrutierend
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases NCT07444606
Noch nicht rekrutierend
Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma NCT07438626
Noch nicht rekrutierend
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia NCT07428486
Noch nicht rekrutierend
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease NCT07415018
Noch nicht rekrutierend
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer NCT07415005
Noch nicht rekrutierend
Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma NCT07414979
Noch nicht rekrutierend
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") NCT07411599
Noch nicht rekrutierend
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia NCT07411586
Noch nicht rekrutierend
Trial of Spiritual Care Interventions for Patients With Cancer NCT07408310
Noch nicht rekrutierend
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial NCT07407920
Aktiv, nicht rekrutierend
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) NCT07401875
Offene Rekrutierung
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms NCT07382817
Offene Rekrutierung
Decoupling Immunotherapy Toxicity and Cancer Response NCT07382752
Offene Rekrutierung
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD" NCT07382739
Noch nicht rekrutierend
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial NCT07382726
Noch nicht rekrutierend
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer NCT07382583
Offene Rekrutierung
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System NCT07382557
Offene Rekrutierung
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss NCT07382544
Offene Rekrutierung
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer NCT07377526
Noch nicht rekrutierend
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer NCT07377006
Noch nicht rekrutierend
A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses NCT07369050
Noch nicht rekrutierend
CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal NCT07335302
Offene Rekrutierung
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations NCT07325253
Offene Rekrutierung
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer NCT07318389
Noch nicht rekrutierend
IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention NCT07318363
Noch nicht rekrutierend
Phase-Ib-Studie zu Avutometinib, Defactinib und Everolimus bei Endometriumkarzinom mit RAS-Signalweg-Mutation NCT07318324
Noch nicht rekrutierend
Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma NCT07316010
Noch nicht rekrutierend
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia NCT07311746
Noch nicht rekrutierend
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE) NCT07298096
Offene Rekrutierung
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins NCT07298083
Noch nicht rekrutierend
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma NCT07283731
Noch nicht rekrutierend
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma NCT07283679
Noch nicht rekrutierend
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial NCT07283653
Offene Rekrutierung
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase NCT07269470
Noch nicht rekrutierend
Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study NCT07257068
Noch nicht rekrutierend
Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study NCT07257055
Noch nicht rekrutierend
A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial NCT07246954
Offene Rekrutierung